25.50
Amphastar Pharmaceuticals Inc stock is traded at $25.50, with a volume of 41,879.
It is down -0.01% in the last 24 hours and up +3.58% over the past month.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
See More
Previous Close:
$25.38
Open:
$25.39
24h Volume:
41,879
Relative Volume:
0.07
Market Cap:
$1.20B
Revenue:
$723.55M
Net Income/Loss:
$157.72M
P/E Ratio:
8.50
EPS:
3
Net Cash Flow:
$170.15M
1W Performance:
-0.60%
1M Performance:
+3.58%
6M Performance:
-43.51%
1Y Performance:
-39.94%
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Name
Amphastar Pharmaceuticals Inc
Sector
Phone
909-980-9484
Address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Compare AMPH with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
AMPH
Amphastar Pharmaceuticals Inc
|
25.50 | 1.20B | 723.55M | 157.72M | 170.15M | 3.00 |
![]()
HLN
Haleon Plc Adr
|
11.18 | 50.54B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
ZTS
Zoetis Inc
|
170.89 | 74.02B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
RDHL
Redhill Biopharma Ltd Adr
|
1.8368 | 4.22M | 35.75M | 11.57M | -26.25M | -3.8069 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.96 | 45.82B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.15 | 20.31B | 16.54B | -1.64B | 749.00M | -1.45 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-12-25 | Downgrade | JP Morgan | Overweight → Neutral |
Feb-04-25 | Downgrade | Piper Sandler | Overweight → Neutral |
Nov-22-24 | Initiated | Wells Fargo | Equal Weight |
Mar-05-24 | Initiated | JP Morgan | Overweight |
Nov-17-23 | Initiated | BofA Securities | Neutral |
Jul-25-23 | Resumed | Jefferies | Buy |
Oct-21-22 | Resumed | Jefferies | Buy |
Jul-29-22 | Initiated | CapitalOne | Overweight |
Jan-07-22 | Upgrade | Piper Sandler | Neutral → Overweight |
Jan-08-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Oct-05-20 | Upgrade | Northland Capital | Market Perform → Outperform |
May-01-20 | Initiated | Northland Capital | Outperform |
Mar-13-19 | Downgrade | Needham | Buy → Hold |
Mar-13-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
Aug-10-18 | Reiterated | Needham | Buy |
Mar-13-18 | Reiterated | Needham | Buy |
Dec-01-17 | Reiterated | Needham | Buy |
Nov-09-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
Sep-27-17 | Reiterated | Needham | Buy |
Mar-14-17 | Downgrade | Raymond James | Strong Buy → Outperform |
Aug-09-16 | Reiterated | Needham | Buy |
May-10-16 | Reiterated | Needham | Buy |
Feb-19-16 | Initiated | Wells Fargo | Outperform |
Jun-19-15 | Reiterated | Needham | Buy |
Jun-03-15 | Initiated | Raymond James | Strong Buy |
Jul-21-14 | Initiated | Needham | Buy |
View All
Amphastar Pharmaceuticals Inc Stock (AMPH) Latest News
Squarepoint Ops LLC Buys 11,929 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest Up 24.9% in May - MarketBeat
Nuveen Asset Management LLC Has $3.55 Million Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar price target lowered to $35 from $40 at Wells Fargo - MSN
Two Sigma Advisers LP Sells 12,400 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
(AMPH) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Man Group plc Buys New Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by Voloridge Investment Management LLC - MarketBeat
Deutsche Bank AG Buys 10,839 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Point72 Asset Management L.P. - MarketBeat
Evolent Health, Amphastar Pharmaceuticals, Iridium, and Magnite Stocks Trade Up, What You Need To Know - Yahoo Finance
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Acquires 792 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Twinbeech Capital LP Invests $1.74 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Deutsche Bank AG Has $1.27 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Ameriprise Financial Inc. Grows Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by BNP Paribas Financial Markets - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Janus Henderson Group PLC - MarketBeat
D. E. Shaw & Co. Inc. Boosts Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Systematic Financial Management LP Makes New $9.15 Million Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs Peers - FinancialContent
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - ACCESS Newswire
Amphastar CFO to Lead Fireside Chat at Jefferies Global Healthcare Conference June 5 - Stock Titan
When the Price of (AMPH) Talks, People Listen - news.stocktradersdaily.com
BNP Paribas Financial Markets Sells 57,502 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Northern Trust Corp Acquires 29,808 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Jane Street Group LLC Raises Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals' (AMPH) "Neutral" Rating Reaffirmed at JPMorgan Chase & Co. - MarketBeat
Comerica Bank Cuts Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by The Manufacturers Life Insurance Company - Defense World
Amphastar Pharmaceuticals (NASDAQ:AMPH) Given “Neutral” Rating at JPMorgan Chase & Co. - Defense World
Amphastar outlines key launches and product growth drivers for 2025 - MSN
Amphastar Pharma (AMPH) Downgraded by JP Morgan with Revised Pri - GuruFocus
This Target Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday - Benzinga
Amphastar stock rating cut to Neutral by JPMorgan - Investing.com Canada
JPMorgan Downgrades Amphastar Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $30 From $45 - marketscreener.com
Amphastar (AMPH) Faces Downgrade Amid Pipeline Challenges | AMPH Stock News - GuruFocus
Amphastar Pharmaceuticals, Comstock, Range Resources - TradingView
Amphastar Pharmaceuticals: Navigating Through An Inflection Year (NASDAQ:AMPH) - Seeking Alpha
Trend Tracker for (AMPH) - news.stocktradersdaily.com
Wells Fargo & Company Lowers Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $35.00 - Defense World
Dimensional Fund Advisors LP Raises Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
U.S. Naloxone Market to Witness Remarkable Growth with Amphastar Pharmaceuticals Inc., Emergent BioSolutions Inc. - openPR.com
Amphastar Pharmaceuticals Inc Stock (AMPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Amphastar Pharmaceuticals Inc Stock (AMPH) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Petersen Floyd F. | Director |
May 01 '25 |
Sale |
24.08 |
500 |
12,041 |
73,409 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):